Subscribe Now
Rankings
Magazine
Newsletters
Podcasts
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
Rankings
See All Rankings
Fortune 500
Global 500
40 Under 40
GREAT PLACE TO WORK LISTS
Best MBA Programs
Magazine
April/May 2023
February/March 2023
December 2022/January 2023
October/November 2022
Newsletters
Podcasts
More
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
SEARCH
SEARCH
SIGN IN
Subscribe Now
sarepta
Newsletters
Does the FDA need to slow its drug approval roll?
BY
Sy Mukherjee
Health
Controversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal
BY
Sy Mukherjee
Newsletters
FDA Approves Sarepta Duchenne Drug in Stunning Reversal
BY
Sy Mukherjee
Health
Why Sarepta Stock Skyrocketed 40% Today
BY
Sy Mukherjee
Health
This Controversial Biotech May Yet Defy Its Skeptics
BY
Sy Mukherjee
Health
Drug Giant Sanofi May Be Getting Ready to Buy Up This Rare Disease Company
BY
Sy Mukherjee
Health
Gilead Just Paid $125 Million to Nab a Big Market Advantage
BY
Sy Mukherjee
Health
Drug Company Hits Pause on Launching an $89,000 Muscular Dystrophy Drug After Backlash
BY
Sy Mukherjee
Health
This Pharma Company Is Selling a Decades-old Drug to Treat Muscular Dystrophy for $89,000
BY
Sy Mukherjee
Health
Insurers are Rebelling Against the FDA’s Most Controversial 2016 Drug Approval
BY
Sy Mukherjee
Health
Why This Controversial Biotech Stock Just Soared More Than 88%
BY
Sy Mukherjee
Health
The FDA’s Most Controversial Drug Approval of the Year Just Hit a Huge Snag
BY
Sy Mukherjee
Health
The FDA Just Made Its Most Controversial Drug Approval of the Year
BY
Sy Mukherjee
Health
This Drug Company’s Shares Are Up 20% Today
BY
Reuters
Health
This Rare Children’s Disease Drug Is Pitting Patients Against the FDA
BY
Sy Mukherjee
Load More
Most Popular
Aging Well
Bruce Willis’ family missed a common early dementia symptom—and they’re not alone. 5 ways to tell if it’s more serious...
BY
Erin Prater
Finance
Elon Musk convinced pals Marc Andreessen, Changpeng Zhao and Prince Al Waleed to invest in Twitter. They’re down 67%,...
BY
Shawn Tully
Europe
U.S. intelligence hacked thousands of iPhones belonging to Russians and diplomats from other countries, Russia says
BY
William Turton
,
Jake Rudnitsky
, and others
